| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000233613.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.048456585 |
Resistant |
| ENSG00000233613.1 |
Tanespimycin |
Colon adenocarcinoma |
0.007096635 |
Sensitive |
| ENSG00000233613.1 |
Tanespimycin |
Esophageal cancer |
0.049595289 |
Sensitive |
